|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7989 USD | +12.74% |
|
-4.81% | -16.82% |
| Jun. 15 | Humacyte, Inc. - Special Call | |
| Jun. 15 | Humacyte Presents Positive Phase 3 Results for Bioengineered Blood Vessel in Women on Dialysis | CI |
| Market Cap | 215M 189M 174M 163M 306M 20.37B 313M 2.1B 809M 10.05B 809M 791M 34.88B | P/E 2026 * |
-2.34x | P/E 2027 * | -3.25x |
|---|---|---|---|---|---|
| Enterprise Value | 215M 189M 174M 163M 306M 20.37B 313M 2.1B 809M 10.05B 809M 791M 34.88B | EV / Sales 2026 * |
34x | EV / Sales 2027 * | 8.19x |
| Free-Float |
92.49% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Humacyte, Inc.
| 1 day | +12.74% | ||
| 1 week | -4.81% | ||
| Current month | -38.55% | ||
| 1 month | -38.55% | ||
| 3 months | +18.25% | ||
| 6 months | -21.68% | ||
| Current year | -16.82% |
| 1 week | 0.61 |  | 0.82 |
| 1 month | 0.61 | | 1.52 |
| Current year | 0.55 | | 1.52 |
| 1 year | 0.55 | | 2.84 |
| 3 years | 0.55 | | 9.97 |
| 5 years | 0.55 | | 17.45 |
| 10 years | 0.55 | | 17.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Laura Niklason
CEO | Chief Executive Officer | 63 | 2020-10-31 |
Dale Sander
DFI | Director of Finance/CFO | 66 | 2021-08-25 |
Shamik Parikh
CTO | Chief Tech/Sci/R&D Officer | 53 | 2022-04-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Niklason
BRD | Director/Board Member | 63 | 2004-10-12 |
Emery Brown
BRD | Director/Board Member | 69 | 2021-08-25 |
| Director/Board Member | 63 | 2021-08-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 10 | Free | Director | 80,000 | 0.0360% | ||
| Jun. 10 | Free | Director | 0 | 0% | ||
| Jun. 10 | Free | Founder | 80,000 | 0.0360% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +12.74% | -4.81% | -62.32% | -73.55% | 215M | |
| +0.67% | +5.78% | -3.54% | +2.17% | 46.62B | |
| +5.79% | +16.17% | +421.86% | +634.63% | 40.95B | |
| +1.12% | +15.18% | +22.74% | -12.71% | 32.26B | |
| +3.61% | +6.69% | +20.23% | +62.38% | 32.24B | |
| +8.02% | +6.35% | +17.67% | +34.73% | 25.53B | |
| +1.13% | +15.66% | - | - | 16.38B | |
| +1.45% | +17.35% | +72.11% | +127.60% | 15.27B | |
| -0.18% | +4.32% | +12.61% | +17.02% | 13.61B | |
| -0.60% | +6.32% | +102.74% | +96.28% | 13.34B | |
| Average | +3.37% | +9.94% | +67.12% | +98.73% | 23.64B | |
| Weighted average by Cap. | +2.78% | +11.57% | +98.06% | +145.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.34M 5.55M 5.13M 4.79M 9.01M 600M 9.22M 61.7M 23.82M 296M 23.82M 23.3M 1.03B | 26.31M 23.03M 21.26M 19.86M 37.38M 2.49B 38.23M 256M 98.78M 1.23B 98.79M 96.62M 4.26B |
| Net income | -78.35M -68.6M -63.33M -59.14M -111M -7.41B -114M -762M -294M -3.65B -294M -288M -12.69B | -62.26M -54.51M -50.32M -46.99M -88.46M -5.89B -90.48M -606M -234M -2.9B -234M -229M -10.08B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | $0.7989 | +12.74% | 36,756,048 |
| 26-06-26 | $0.7086 | +14.29% | 46,984,521 |
| 26-06-25 | $0.6200 | -11.14% | 25,464,075 |
| 26-06-24 | $0.6977 | -0.39% | 29,486,464 |
| 26-06-23 | $0.7004 | -16.55% | 46,220,877 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HUMA Stock
Select your edition
All financial news and data tailored to specific country editions
